SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kos Pharmaceuticals, Inc (KOSP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom D who wrote (11)9/1/1997 7:33:00 PM
From: Tom D   of 118
 
An "N" is a better description...

of my prediction for Kos' price than a "U", as I think about it more carefully. Just look at a two year chart of Fuisz (Nasdaq ticker FUSE) and you will see what I fear. Although I am now above my average cost on FUSE, I did buy a thousand shares in May '97 at 10% below the all-time high. Just because Kos has fallen 13% from its high, don't be fooled into think I am a smart investor. I am skeptical because I have been burned before. I did not sell Kos short, although I was tempted, because its hard to know where the top of the "N" is.

Incidentally, did everybody notice that the patent on Niaspan expires in only three years. Of course there are other drugs coming, but it is a sobering thought.

Tom D
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News